Exactech Goes Private in $625M Deal With TPG Capital Post author:Sam Post published:October 22, 2017 Post category:BioPharma TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share. Source: BioSpace You Might Also Like Clarify Medical Core Technology Receives FDA Clearance June 5, 2017 Where High-Flying Cara Therapeutics Could be in 5 Years October 5, 2017 Meet the 29-Year-Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) January 26, 2017
Meet the 29-Year-Old Man Who Just Launched Biotech Startup Advanced Modular Instruments (AMI) January 26, 2017